Qtern

Active Ingredient(s): Dapagliflozin + Saxagliptin
FDA Approved: * February 27, 2017
Pharm Company: * ASTRAZENECA AB
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Qtern Overview

Dapagliflozin, sold under the brand name Farxiga among others, is a medication used to treat type 2 diabetes. It is of the gliflozin class. It was developed by Bristol-Myers Squibb in partnership with AstraZeneca. Contents 1 Medical uses 2 Adverse effects 3 Mechanism of action 3.1 Selectivity 4 Names 5 Research 6 References 7 External links Medical uses Dapagliflozin is used along with diet and exercise to improve glycemic control in adults with type 2 diabetes.[2]...

Read more Qtern Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dapagliflozin

Recent Qtern Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Dapagliflozin + Saxagliptin
  • Tablet: 10mg + 5mg, 5mg + 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Qtern: (2 results)

Sorted by National Drug Code
  • 0310-6770 Qtern Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp
  • 0310-6780 Qtern Oral Tablet, Film Coated by Astrazeneca Pharmaceuticals Lp

Drugs with one or more similar ingredients: (11 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA